Lv7
4960 积分 2024-01-22 加入
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
9天前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
17天前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
17天前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
23天前
已完结
Batoclimab vs Placebo for Generalized Myasthenia Gravis
23天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
23天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
23天前
已完结
Myasthenia gravis: Mechanisms, clinical syndromes, and diagnosis
23天前
已完结
The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis
23天前
已完结
Membranous nephropathy
1个月前
已完结
皖公网安备34019202002308
